N@N

China Kanghui Holdings Announces Board of Director Changes

^{Published on 2010-11-08 03:41:11 - Market Wire}
 

CHANGZHOU, China--([ BUSINESS WIRE ])--China Kanghui Holdings (NYSE: KH) (aKanghuia or the aCompanya), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced the appointment of Mr. David Su to the Companya™s Board of Directors in the role of independent director. Mr. Su replaces Mr.James Yiping Li, who has resigned from the position, effective immediately.

Mr. Su brings to Kanghui considerable experience operating China-based businesses across multiple sectors, including in Chinaa™s healthcare and medical technology sector. Mr. Su has been a managing partner at Matrix Partners China and has led the firma™s investments in the internet, digital media and medical technology since 2008. From 2007 to 2008, he was a partner at KPCB China, and from 2003 to 2008, he was a general partner and managing director at Venture TDF China and TDF Capital. Mr. Su received his bachelora™s in Applied Science (Computer Engineering) from Nanyang Technological University in Singapore. In addition, Mr. Su currently serves on the boards of AdSame Network and Bona Film Group.

The board wishes to thank Mr.Li for his outstanding contribution to Kanghuia™s development and all the best for his future endeavors.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghuia™s products are distributed in 24 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit [ www.kanghui.com ].

Safe-Harbor Statement

This press release contains statements of a forward-looking nature. These statements are made under the asafe harbora provisions of the Private Securities Litigation Reform Act of 1995, including certain plans, expectations, goals, and projections, which are subject to numerous assumptions, risks, and uncertainties. These forward-looking statements may include, but are not limited to, statements containing words such as amay,a acould,a awould,a aplan,a aanticipate,a abelieve,a aestimate,a apredict,a apotential,a aexpects,a aintendsa and afuturea or similar expressions. Among other things, the statements relating to the Companya™s expected progress on the new product portfolio may contain forward-looking statements. These forward-looking statements speak only as of the date of this press release and are subject to change at any time. These forward-looking statements are based upon management's current expectations and are subject to a number of risks, uncertainties and contingencies, many of which are beyond the Companya™s control that may cause actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. The Companya™s actual results could differ materially from those contained in the forward-looking statements due to a number of factors, including those described under the heading aRisk Factorsa in the Companya™s final prospectus as filed with the Securities and Exchange Commission, and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission